RT Journal Article
T1 SEOM clinical guideline on hereditary colorectal cancer (2019).
A1 Guillen-Ponce, C
A1 Lastra, E
A1 Lorenzo-Lorenzo, I
A1 Martin Gomez, T
A1 Morales Chamorro, R
A1 Sanchez-Heras, A B
A1 Serrano, R
A1 Soriano Rodriguez, M C
A1 Soto, J L
A1 Robles, L
K1 Adenomatous polyposis
K1 Colon cancer
K1 Hereditary colorectal cancer
K1 Lynch syndrome
AB In the last 2 decades, clinical genetics on hereditary colorectal syndromes has shifted from just a molecular characterization of the different syndromes to the estimation of the individual risk of cancer and appropriate risk reduction strategies. In the last years, new specific therapies for some subgroups of patients have emerged as very effective alternatives. At the same time, germline multigene panel testing by next-generation sequencing (NGS) technology has become the new gold standard for molecular genetics.
PB Springer
YR 2019
FD 2019-12-16
LK http://hdl.handle.net/10668/15004
UL http://hdl.handle.net/10668/15004
LA en
NO Guillén-Ponce C, Lastra E, Lorenzo-Lorenzo I, Martín Gómez T, Morales Chamorro R, Sánchez-Heras AB, et al. SEOM clinical guideline on hereditary colorectal cancer (2019). Clin Transl Oncol. 2020 Feb;22(2):201-212
DS RISalud
RD Apr 17, 2025